PDB Short entry for 1PS2 HEADER GROWTH FACTOR 07-JAN-97 1PS2 TITLE HIGH RESOLUTION NMR SOLUTION STRUCTURE OF HUMAN PS2, 19 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PS2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PNR-2; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: HB101; SOURCE 6 ORGAN: BREAST, STOMACH; SOURCE 7 TISSUE: EPITHELIAL; SOURCE 8 CELL: MCF-7, UACL; SOURCE 9 CELLULAR_LOCATION: EXTRACELLULAR; SOURCE 10 GENE: BCEI; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 14 EXPRESSION_SYSTEM_CELL_LINE: HB101; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_VECTOR: PHARMACIA PEZZ18; SOURCE 17 EXPRESSION_SYSTEM_GENE: BCEI KEYWDS GROWTH FACTOR, CELL MOTILITY, TUMOR SUPPRESSOR, TREFOIL DOMAIN EXPDTA SOLUTION NMR NUMMDL 19 AUTHOR M.A.WILLIAMS,V.I.POLSHAKOV,A.R.GARGARO,J.FEENEY REVDAT 3 03-NOV-21 1PS2 1 REMARK SEQADV REVDAT 2 24-FEB-09 1PS2 1 VERSN REVDAT 1 07-JUL-97 1PS2 0 JRNL AUTH V.I.POLSHAKOV,M.A.WILLIAMS,A.R.GARGARO,T.A.FRENKIEL, JRNL AUTH 2 B.R.WESTLEY,M.P.CHADWICK,F.E.MAY,J.FEENEY JRNL TITL HIGH-RESOLUTION SOLUTION STRUCTURE OF HUMAN PNR-2/PS2: A JRNL TITL 2 SINGLE TREFOIL MOTIF PROTEIN. JRNL REF J.MOL.BIOL. V. 267 418 1997 JRNL REFN ISSN 0022-2836 JRNL PMID 9096235 JRNL DOI 10.1006/JMBI.1997.0896 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.P.CHADWICK,F.E.MAY,B.R.WESTLEY REMARK 1 TITL PRODUCTION AND COMPARISON OF MATURE SINGLE-DOMAIN 'TREFOIL' REMARK 1 TITL 2 PEPTIDES PNR-2/PS2 CYS58 AND PNR-2/PS2 SER58 REMARK 1 REF BIOCHEM.J. V. 308 1001 1995 REMARK 1 REFN ISSN 0264-6021 REMARK 1 REFERENCE 2 REMARK 1 AUTH V.I.POLSHAKOV,T.A.FRENKIEL,B.WESTLEY,M.CHADWICK,F.MAY, REMARK 1 AUTH 2 M.D.CARR,J.FEENEY REMARK 1 TITL NMR-BASED STRUCTURAL STUDIES OF THE PNR-2/PS2 SINGLE DOMAIN REMARK 1 TITL 2 TREFOIL PEPTIDE. SIMILARITIES TO PORCINE SPASMOLYTIC PEPTIDE REMARK 1 TITL 3 AND EVIDENCE FOR A MONOMERIC STRUCTURE REMARK 1 REF EUR.J.BIOCHEM. V. 233 847 1995 REMARK 1 REFN ISSN 0014-2956 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PS2 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175818. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2-D H-1-H HOMONUCLEAR COSY; REMARK 210 TOCSY; ROESY AND NOESY. 1-H/15-N REMARK 210 HSQC-NOESY; HNHA; HNHB REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : UNITY; UNITYPLUS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR 3.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 19 REMARK 210 CONFORMERS, SELECTION CRITERIA : TOTAL NOE CONSTRAINT VIOLATIONS REMARK 210 < 1.0 A REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 13 38.38 -84.33 REMARK 500 1 VAL A 22 -178.97 -60.17 REMARK 500 1 PRO A 24 -36.45 -36.05 REMARK 500 1 ASP A 36 70.42 -115.34 REMARK 500 2 ALA A 2 33.69 -158.79 REMARK 500 2 VAL A 22 -176.31 -60.25 REMARK 500 2 ASP A 51 -166.66 -107.29 REMARK 500 3 GLU A 13 43.03 -92.29 REMARK 500 3 VAL A 22 -171.21 -60.62 REMARK 500 3 PRO A 24 -36.37 -34.91 REMARK 500 3 ASP A 36 77.27 -116.32 REMARK 500 4 ALA A 2 37.59 -155.65 REMARK 500 4 PRO A 11 -33.92 -37.62 REMARK 500 4 GLU A 13 40.97 -82.73 REMARK 500 4 PRO A 24 -37.35 -36.33 REMARK 500 4 ASP A 36 48.55 -107.09 REMARK 500 5 ALA A 2 84.75 -160.20 REMARK 500 5 CYS A 7 45.33 -104.02 REMARK 500 5 PRO A 11 -28.79 -38.23 REMARK 500 5 GLU A 13 44.40 -90.56 REMARK 500 5 PRO A 24 -36.12 -34.88 REMARK 500 5 ASP A 36 76.12 -113.76 REMARK 500 6 ALA A 2 70.61 -166.59 REMARK 500 6 THR A 4 -165.75 -171.77 REMARK 500 6 PRO A 11 -31.32 -39.75 REMARK 500 6 GLU A 13 50.82 -103.58 REMARK 500 6 VAL A 22 -171.94 -60.54 REMARK 500 6 PRO A 24 -31.93 -34.71 REMARK 500 6 ASP A 36 64.55 -110.91 REMARK 500 6 ASN A 48 79.22 -168.79 REMARK 500 6 PRO A 54 128.05 -33.63 REMARK 500 7 CYS A 7 45.84 -97.31 REMARK 500 7 PRO A 11 -38.75 -36.87 REMARK 500 7 GLU A 13 42.68 -86.24 REMARK 500 7 VAL A 22 -172.38 -61.06 REMARK 500 7 PRO A 24 -39.75 -35.07 REMARK 500 7 ASP A 35 89.25 -157.63 REMARK 500 7 ASP A 36 78.68 -103.05 REMARK 500 7 VAL A 52 79.69 -114.12 REMARK 500 7 PRO A 54 154.60 -37.47 REMARK 500 8 GLU A 13 40.52 -81.88 REMARK 500 8 PRO A 24 -33.03 -34.49 REMARK 500 8 ASP A 36 59.49 -108.08 REMARK 500 8 THR A 49 92.89 -65.90 REMARK 500 8 PRO A 53 162.27 -38.85 REMARK 500 8 PRO A 54 -72.91 -90.68 REMARK 500 9 PRO A 11 -38.84 -37.93 REMARK 500 9 GLU A 13 50.03 -102.53 REMARK 500 9 PRO A 24 -31.87 -34.58 REMARK 500 9 ASP A 36 66.06 -113.55 REMARK 500 REMARK 500 THIS ENTRY HAS 107 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1PS2 A 1 60 UNP P04155 TFF1_HUMAN 25 84 SEQADV 1PS2 SER A 58 UNP P04155 CYS 82 ENGINEERED MUTATION SEQRES 1 A 60 GLU ALA GLN THR GLU THR CYS THR VAL ALA PRO ARG GLU SEQRES 2 A 60 ARG GLN ASN CYS GLY PHE PRO GLY VAL THR PRO SER GLN SEQRES 3 A 60 CYS ALA ASN LYS GLY CYS CYS PHE ASP ASP THR VAL ARG SEQRES 4 A 60 GLY VAL PRO TRP CYS PHE TYR PRO ASN THR ILE ASP VAL SEQRES 5 A 60 PRO PRO GLU GLU GLU SER GLU PHE HELIX 1 1 PRO A 24 LYS A 30 1 7 SHEET 1 A 2 CYS A 33 PHE A 34 0 SHEET 2 A 2 CYS A 44 PHE A 45 -1 N PHE A 45 O CYS A 33 SSBOND 1 CYS A 7 CYS A 33 1555 1555 2.02 SSBOND 2 CYS A 17 CYS A 32 1555 1555 2.02 SSBOND 3 CYS A 27 CYS A 44 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000